Boehringer AG 13D/13G Filings for Minerva Neurosciences, Inc. (NERV)

Boehringer AG 13D and 13G filings for Minerva Neurosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-07-07
4:18 pm
Purchase
2023-06-2713DMinerva Neurosciences, Inc.
NERV
Boehringer AG1,500,225
20.790%
1,500,225increase
(New Position)
Filing